Michael Dabrow is an Oncology physician affiliated with Paoli Hospital. OpenAlex indexes 16 publications with 579 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
47.1%Estrogen Agonist/Antagonist14.4%Tamoxifen Citrate100%Part D≥17 patientsKinase inhibitor12.4%Imbruvica67%Tasigna33%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
14.7%Serotonin-3 Receptor Antagonist14.7%Ondansetron Hcl100%Part D≥37 patientsNervous system
14.1%Phenothiazine14.1%Prochlorperazine Maleate100%Part D≥38 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Implementing a Standardized Risk Model for Chemotherapy Adverse Events in Older Oncology Patients in a Community Cancer Center
The Medicine Forum
2016 - Phase II Trial of Cetuximab With or Without Paclitaxel in Patients With Advanced Urothelial Tract Carcinoma
Journal of Clinical Oncology
2012 - Evaluation of cognitive function and quality of life in breast cancer patients receiving adjuvant dose dense chemotherapy.
Journal of Clinical Oncology
2012 - Synchronous Diagnosis of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Journal of Clinical Oncology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”